HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cognitive function at 2443 μmol/l creatinine.

AbstractBACKGROUND:
One hallmark of uremia is the impairment of neuro-cognitive function. Anecdotal clinical description from the early days of chronic dialysis therapy impressively illustrates the improvement of those functions by chronic hemodialysis treatment. Fortunately, today, uremia is only rarely observed in industrialized countries as many patients seek medical/nephrological attention prior to the occurrence of deadly complications of uremia.
CASE PRESENTATION:
We report a rare case of severe uremia and describe the day to day improvement in neuro-cognitive function by dialysis using state of the arte test battery--starting at a serum creatinine of 2443 μmol/l.
CONCLUSIONS:
Especially executive functions, which are assumed to be localized in the frontal cerebral regions, are impaired in severe uremia and improve remarkably with the correction of severe uremia, i.e., initiation of dialysis.
AuthorsSabrina Schneider, Anne-Kathrin Malecki, Olaf Boenisch, Robby Schönfeld, Jan T Kielstein
JournalBMC nephrology (BMC Nephrol) Vol. 13 Pg. 86 (Aug 15 2012) ISSN: 1471-2369 [Electronic] England
PMID22894168 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Creatinine
Topics
  • Adult
  • Biomarkers (blood)
  • Cognition Disorders (blood, diagnosis, therapy)
  • Creatinine (blood)
  • Humans
  • Male
  • Renal Dialysis (methods)
  • Uremia (blood, diagnosis, therapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: